CCP
JNJ icon

Cane Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Cane Capital Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
4,878
+1,256
+35% +$293K 0.49% 49
2026
Q1 		$885K Sell
3,622
-3,065
-46% -$714K 0.39% 51
2025
Q4 		$1.38M Buy
+6,687
New +$1.32M 0.54% 38

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cane Capital Partners's JNJ Position: Q2 2026 in Review

Cane Capital Partners increased its Johnson & Johnson (JNJ) stake by 35% in Q2 2026, buying an estimated $293K and bringing the position to 4,878 shares worth $1.24M. The position accounts for 0.49% of the portfolio, ranked #49.

Cane Capital Partners first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.38M in Q4 2025. 4,650 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cane Capital Partners held 4,878 shares of Johnson & Johnson worth $1.24M as of Q2 2026.
  • Cane Capital Partners bought 1,256 Johnson & Johnson shares in Q2 2026, an estimated $293K.
  • Johnson & Johnson made up 0.49% of Cane Capital Partners's portfolio in Q2 2026, its #49 holding.
  • Cane Capital Partners first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Cane Capital Partners's Johnson & Johnson position peaked at $1.38M in Q4 2025.
  • 4,650 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cane Capital Partners's 13F filing for Q2 2026, filed 5 Aug 2026.